- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-02-0065075

Dr.Mark Laboratories Private Limited
About Dr.Mark Laboratories Private Limited
Data last updated:
Dr.Mark Laboratories Private Limited is a private limited company based in Panjagutta, Telangana, India. It operates in the scientific research segment of the research and development sector. It was incorporated on 09 May 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2022PTC162454.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Markandeya Bekkam and Rambabu Vanaparthy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 502 #6 – 3 – 347/24 Dwarakapuri Colony, Panjagutta, Telangana, India – 500082.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.48 Lakh, a growth of 112% compared to the previous year. For the same year it recorded a net profit of ₹1.02 Lakh (net margin 2.6%) and EBITDA of ₹1.06 Lakh (EBITDA margin 2.7%).
The company is associated with 1 brand: Drmarklabs.
Dr.Mark Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0065075).
Company details
Recognitions & Rankings of Dr.Mark Laboratories
Contact details
Dr.Mark Laboratories Private Limited's registered office is in Panjagutta, Telangana.
- Registered AddressFlat No. 502 #6 – 3 – 347/24 Dwarakapuri Colony, Panjagutta, Telangana, India – 500082
- IndustryResearch & Development, Science Research
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Dr.Mark Laboratories operates one associated brand: Drmarklabs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Research and development of pharmaceutical products, APIs, intermediates, and contract services for clients. | drmarklabs.com |
Business activity
The main business activity of Dr.Mark Laboratories is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Dr.Mark Laboratories Private Limited, buy the company report.
Financials of Dr.Mark Laboratories Private Limited
FY 2025 filings availableDr.Mark Laboratories Private Limited reported revenue of ₹39.48 Lakh (up 112% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 112% in the latest year. EBITDA rose 136% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.06 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.02 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 2.7% | ||
| Net Profit Margin | 2.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Dr.Mark Laboratories Private Limited, buy the company report.
Board of directors of Dr.Mark Laboratories Private Limited
Dr.Mark Laboratories has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Markandeya Bekkam | Director | 09 May 2022 | 4 Years 5 Months | Current |
| Rambabu Vanaparthy | Director | 09 May 2022 | 4 Years 5 Months | Current |
Peer comparison
Dr.Mark Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rkshakindia Health Care and Research Centre Private Limited | ₹39.8 Lakh (FY 2024) | 47.0% | Noida, Uttar Pradesh, India | |||
| Panha Life Care Private Limited | ₹39.72 Lakh (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| NGS Biotech Private Limited | ₹39.58 Lakh (FY 2024) | -24.0% | New Delhi, Delhi, India | |||
| Aarogaya Vedic Natural Care Private Limited | ₹39.51 Lakh (FY 2020) | -15.0% | Bhopal, Madhya Pradesh, India | |||
| Deep Ganga Wellness Private Limited | ₹39.49 Lakh (FY 2025) | -28.0% | Mumbai, Maharashtra, India | |||
| Dr.Mark Laboratories Private Limitedthis company | ₹39.48 Lakh (FY 2025) | ₹1.02 Lakh | 2.6% | 112.0% | Panjagutta, Telangana, India | |
| Dialq Kidney Care Private Limited | ₹39.45 Lakh (FY 2024) | 104.0% | Hapur, Uttar Pradesh, India | |||
| Allitis Healthcare Private Limited | ₹39.44 Lakh (FY 2025) | -18.0% | Delhi, India | |||
| Magizhnalamanai Health Care Private Limited | ₹39.4 Lakh (FY 2025) | 3.0% | Chennai, Tamil Nadu, India | |||
| Medcoaid Sun India Private Limited | ₹39.4 Lakh (FY 2025) | 356.0% | Bhubaneswar, Odisha, India | |||
| Jai Hospital and Research Centre Private Limited | ₹39.39 Lakh (FY 2025) | -31.0% | Uttar Pradesh, India |
To see the full peer comparison of Dr.Mark Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dr.Mark Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dr.Mark Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Dr.Mark Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Dr.Mark Laboratories Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Markandeya Bekkam was appointed as Director on 09 May 2022.
Frequently asked questions
Dr.Mark Laboratories is an active private limited company based in Panjagutta, Telangana, India. The company works in science research, within the research and development industry. It was incorporated on 09 May 2022 (4+ years old) and is registered under CIN U73100TG2022PTC162454.
Dr.Mark Laboratories has 2 current directors:
- Markandeya Bekkam - Director
- Rambabu Vanaparthy - Director
The latest financial statements of Dr.Mark Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Dr.Mark Laboratories is U73100TG2022PTC162454. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr.Mark Laboratories was incorporated on 09 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Dr.Mark Laboratories by revenue are Rkshakindia Health Care and Research Centre Private Limited, Panha Life Care Private Limited, NGS Biotech Private Limited, Aarogaya Vedic Natural Care Private Limited, Deep Ganga Wellness Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Markandeya Bekkam was appointed as Director on 09 May 2022. Rambabu Vanaparthy was appointed as Director on 09 May 2022.
Yes, Dr.Mark Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0065075).
The registered office of Dr.Mark Laboratories is at Flat No. 502 #6 – 3 – 34724 Dwarakapuri Colony, Panjagutta, Telangana, India – 500082.
Dr.Mark Laboratories operates in the research and development industry, in the science research segment.
Dr.Mark Laboratories has 1 associated brand: Drmarklabs.